Current stock page

Financial Data

CAI Financial Data

Revenue · Earnings · Margins · Balance Sheet · Cash Flow

HealthcareBiotechnologyScore data as of Nov 13, 2026

CAICaris Life Sciences, Inc.

Healthcare / Biotechnology

Leader

Strong Relative Position

BullishEdge 9/10
$23.04−$0.92 (−3.84%)

Latest quote

  • Momentum
    85
  • Value
    68
  • Quality
    71
  • Risk resilience
    36
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

Financial Data Overview

Detailed revenue, earnings, margins, balance sheet, cash flow, valuation metrics, technical indicators, and risk measures for deeper research.

Quarterly periods
0
Fundamental metrics
10
Technical indicators
12
Risk measures
6

Quarterly Financial Statements

Updated —.

Income statement
0 periods

No quarterly history is available for this statement.

Cash flow statement
0 periods

No quarterly history is available for this statement.

Balance sheet
0 periods

No quarterly history is available for this statement.

Key financial metrics
0 periods

No quarterly history is available for this statement.

Financial ratios
0 periods

No quarterly history is available for this statement.

Current Stock Metrics

Current fundamental, technical, and risk readings in one place.

Fundamental metrics
MetricValue
Pe68.59x
Pb10.23x
Gross Margin69.09%
Operating Margin13.35%
ROE16.00%
ROIC12.49%
Debt To Equity0.72
FCF Yield0.78%

As of Nov 13, 2026

Technical indicators
MetricValue
Close$23.04
Volume3.02M
RSI (14)30.87
MACD-1.63
MACD signal-0.46
MACD histogram-1.17
ADX (14)37.3
SMA (50)$29.39
SMA (200)$21.63
ATR (14)$2.19
Historical volatility (annualized)91.65%
Volume (20-day average)3.96M

As of Nov 13, 2026

Risk measures
MetricValue
Resilience score36/100
Beta1.85
Annual volatility69.82%
Max Drawdown-49.58%
Sharpe Ratio0.22
VaR (95%, 1-day)-6.29%

As of Nov 13, 2026

Detailed Metrics

Additional measures remain available here while the decision pages stay focused.

Additional fundamental metrics

No additional fundamental metrics are available.

Additional technical indicators

No additional technical indicators are available.

Additional risk measures

No additional risk measures are available.

CAI Financial Data FAQ

What is Caris Life Sciences, Inc.'s revenue?

Caris Life Sciences, Inc.'s revenue is one of the core financial data points for CAI. Use it with revenue growth, margins, and EPS to understand whether sales are translating into earnings power.

Is Caris Life Sciences, Inc.'s revenue growing?

Revenue growth shows whether Caris Life Sciences, Inc. is expanding from prior periods. Compare growth with margins and free cash flow because faster sales growth is more valuable when profitability holds up.

What is CAI's EPS?

CAI's EPS, or earnings per share, helps connect net income to each share. EPS should be compared with EPS growth, P/E ratio, and analyst expectations.

What is Caris Life Sciences, Inc.'s net income?

Caris Life Sciences, Inc.'s net income shows profit after costs, taxes, and other expenses. It should be read with revenue, operating margin, EPS, and free cash flow.

How much free cash flow does Caris Life Sciences, Inc. generate?

Free cash flow shows how much cash Caris Life Sciences, Inc. generates after capital spending. It is useful for judging reinvestment capacity, buybacks, debt reduction, and valuation support.

How much cash and debt does Caris Life Sciences, Inc. have?

Cash and debt help frame CAI's balance-sheet flexibility. Compare liquidity and leverage with free cash flow and profitability before judging financial strength.